Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MAPK7 contributors: mct - updated : 31-08-2018
HGNC name mitogen-activated protein kinase 7
HGNC id 6880
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
constitutional   deletion    
in Smith-Magenis syndrome
tumoral   amplification    
in hepatocellular carcinoma
tumoral     --over  
might contribute to ovarian cancer metastasis through up-regulating type II collagen expression ( might contribute to ovarian cancer metastasis through up-regulating type II collagen expression
Susceptibility
Variant & Polymorphism other
Candidate gene
Marker
  • MAPK7 and MAP2K4 could be good markers in assessing response to treatment and development of osteosarcoma
  • may be a new prognostic marker in clear cell renal cell carcinoma owing to its relationship with metastasis and more advanced stages
  • Therapy target
    SystemTypeDisorderPubmed
    cancerdigestiveliver
    cancerbone 
    may be a new therapeutic target in invasive osteosarcoma expressing MMP9
    diabetetype 1 
    may be a promising target for increasing beta-cell mass in diabetes patients
    cardiovascularcardiomyopathy 
    maintenance of cardiac MAPK7 is a therapeutic approach for cardiomyopathy prevention and/or treatment
    cancerreproductiveovary
    may be a potential therapeutic target in the clinical treatment for ovarian cancer
    immunologyinflammatory 
    is a potential therapeutic target in diverse disorders that cause inflammatory critical illness
    cardiovascularatheroma 
    Molecules that upregulate ERK5 and its signaling in macrophages may be good drug targets for suppressing cardiovascular diseases
    ANIMAL & CELL MODELS
  • Erk4-deficient mice are viable and fertile and exhibit no gross morphological or physiological anomalies
  • conditional deletion of the erk5 gene in mouse neural stem cells during development reduces the number of GABAergic interneurons in the main olfactory bulb (OB)